Gene · 30849
Papers1,576
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,576
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of Protein-Membrane Interactions in Yeast Autophagy. | Cells | 2022 | 35741004 | PubTator, text mining | PubMed |
| BECLIN-1-Mediated Autophagy Suppresses Silica Nanoparticle-Induced Testicular Toxicity via the Inhibition of Caspase 8-Mediated Cell Apoptosis in Leydig Cells. | Cells | 2022 | 35740992 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma. | BMC Cancer | 2022 | 35715770 | PubTator, text mining | PubMed |
| NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process. | iScience | 2022 | 35712081 | PubTator, text mining | PubMed |
| Autophagy Dysfunction in ALS: from Transport to Protein Degradation. | J Mol Neurosci | 2022 | 35708843 | PubTator, text mining | PubMed |
| Current strategies to induce selective killing of HIV-1-infected cells. | J Leukoc Biol | 2022 | 35707952 | PubTator, text mining | PubMed |
| Decrypting a path based approach for identifying the interplay between PI3K and GSK3 signaling cascade from the perspective of cancer. | Genes Dis | 2022 | 35685456 | PubTator, text mining | PubMed |
| Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. | Molecules | 2022 | 35684434 | PubTator, text mining | PubMed |
| The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review. | Int J Mol Sci | 2022 | 35682754 | PubTator, text mining | PubMed |
| Ginsenoside Rh4 Inhibits Colorectal Cancer Cell Proliferation by Inducing Ferroptosis via Autophagy Activation. | Evid Based Complement Alternat Med | 2022 | 35677385 | PubTator, text mining | PubMed |
| Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis. | Front Oral Health | 2022 | 35677025 | PubTator, text mining | PubMed |
| Integrating intracellular nanovesicles into integrin trafficking pathways and beyond. | Cell Mol Life Sci | 2022 | 35657500 | PubTator, text mining | PubMed |
| Pathophysiology of Primary Cilia: Signaling and Proteostasis Regulation. | Front Cell Dev Biol | 2022 | 35646931 | PubTator, text mining | PubMed |
| H1.0 induces paclitaxel-resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor. | Cancer Sci | 2022 | 35639349 | PubTator, text mining | PubMed |
| Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux. | Antioxidants (Basel) | 2022 | 35624874 | PubTator, text mining | PubMed |
| Shabyar Ameliorates High Glucose Induced Retinal Pigment Epithelium Injury Through Suppressing Aldose Reductase and AMPK/mTOR/ULK1 Autophagy Pathway. | Front Pharmacol | 2022 | 35620285 | PubTator, text mining | PubMed |
| Recent Advances of Autophagy in Non-Small Cell Lung Cancer: From Basic Mechanisms to Clinical Application. | Front Oncol | 2022 | 35600411 | PubTator, text mining | PubMed |
| Phosphoinositides as membrane organizers. | Nat Rev Mol Cell Biol | 2022 | 35589852 | PubTator, text mining | PubMed |
| Programmed cell death in atherosclerosis and vascular calcification. | Cell Death Dis | 2022 | 35585052 | PubTator, text mining | PubMed |
| A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma. | Front Oncol | 2022 | 35574327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/30849/papers?page=18